All Cosmos Bio-Tech Holding Corp
TWSE:4148
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.45
49.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
All Cosmos Bio-Tech Holding Corp
stock under the Base Case scenario is
36.13
TWD.
Compared to the current market price of 38.3 TWD,
All Cosmos Bio-Tech Holding Corp
is
Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for All Cosmos Bio-Tech Holding Corp.
| US |
|
Corteva Inc
NYSE:CTVA
|
|
| CA |
|
Nutrien Ltd
TSX:NTR
|
|
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
|
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
|
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
|
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
|
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
|
| NO |
|
Yara International ASA
OSE:YAR
|
|
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
|
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
All Cosmos Bio-Tech Holding Corp
Balance Sheet Decomposition
All Cosmos Bio-Tech Holding Corp
| Current Assets | 2.8B |
| Receivables | 828m |
| Other Current Assets | 2B |
| Non-Current Assets | 1.1B |
| Long-Term Investments | 199m |
| PP&E | 859m |
| Intangibles | 10.4m |
| Other Non-Current Assets | 32.6m |
| Current Liabilities | 535m |
| Accounts Payable | 138m |
| Accrued Liabilities | 94m |
| Short-Term Debt | 184m |
| Other Current Liabilities | 119m |
| Non-Current Liabilities | 797m |
| Long-Term Debt | 122m |
| Other Non-Current Liabilities | 675m |
Free Cash Flow Analysis
All Cosmos Bio-Tech Holding Corp
| TWD | |
| Free Cash Flow | TWD |
Earnings Waterfall
All Cosmos Bio-Tech Holding Corp
|
Revenue
|
2.8B
TWD
|
|
Cost of Revenue
|
-2B
TWD
|
|
Gross Profit
|
788.3m
TWD
|
|
Operating Expenses
|
-524.6m
TWD
|
|
Operating Income
|
263.7m
TWD
|
|
Other Expenses
|
-125.7m
TWD
|
|
Net Income
|
138m
TWD
|
Profitability Score
Profitability Due Diligence
All Cosmos Bio-Tech Holding Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
All Cosmos Bio-Tech Holding Corp's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
All Cosmos Bio-Tech Holding Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
All Cosmos Bio-Tech Holding Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
All Cosmos Bio-Tech Holding Corp
Dividends
Current shareholder yield for
All Cosmos Bio-Tech Holding Corp is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
All Cosmos Bio-Tech Holding Corp
stock under the Base Case scenario is
36.13
TWD.
Compared to the current market price of 38.3 TWD,
All Cosmos Bio-Tech Holding Corp
is
Overvalued by 6%.